Acadia Healthcare (NASDAQ:ACHC) Price Target Cut to $83.00 by Analysts at Barclays

Acadia Healthcare (NASDAQ:ACHC) had its target price decreased by Barclays from $89.00 to $83.00 in a report issued on Thursday morning, Benzinga reports. Barclays currently has an overweight rating on the stock.

Other analysts have also issued research reports about the stock. Cantor Fitzgerald reiterated a neutral rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, July 9th. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a sell rating to a hold rating and set a $70.00 price objective for the company in a research note on Thursday, April 25th. Bank of America lowered their price objective on shares of Acadia Healthcare from $105.00 to $90.00 and set a buy rating for the company in a research note on Thursday, May 2nd. TD Cowen lowered their price objective on shares of Acadia Healthcare from $101.00 to $91.00 and set a buy rating for the company in a research note on Friday, May 17th. Finally, StockNews.com lowered shares of Acadia Healthcare from a hold rating to a sell rating in a research note on Tuesday, May 21st. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, Acadia Healthcare has a consensus rating of Moderate Buy and an average price target of $87.44.

Acadia Healthcare Stock Down 2.3 %

Acadia Healthcare stock opened at $72.37 on Thursday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.27 and a current ratio of 1.18. Acadia Healthcare has a 52-week low of $62.04 and a 52-week high of $87.77. The firm has a 50 day moving average price of $67.23 and a two-hundred day moving average price of $73.62. The firm has a market cap of $6.71 billion, a price-to-earnings ratio of -516.89, a PEG ratio of 2.21 and a beta of 1.32.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.87 by $0.04. The firm had revenue of $796.00 million during the quarter, compared to analyst estimates of $784.38 million. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The company’s revenue was up 8.8% compared to the same quarter last year. During the same quarter last year, the business earned $0.92 EPS. Equities analysts predict that Acadia Healthcare will post 3.51 EPS for the current year.

Hedge Funds Weigh In On Acadia Healthcare

A number of hedge funds have recently bought and sold shares of the company. Natixis Advisors LLC boosted its holdings in shares of Acadia Healthcare by 43.9% in the 2nd quarter. Natixis Advisors LLC now owns 175,895 shares of the company’s stock worth $11,879,000 after buying an additional 53,690 shares during the last quarter. nVerses Capital LLC purchased a new position in shares of Acadia Healthcare in the 2nd quarter worth about $95,000. Commonwealth Equity Services LLC boosted its holdings in shares of Acadia Healthcare by 3.5% in the 2nd quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock worth $513,000 after buying an additional 257 shares during the last quarter. Sivik Global Healthcare LLC boosted its holdings in shares of Acadia Healthcare by 14.3% in the 2nd quarter. Sivik Global Healthcare LLC now owns 80,003 shares of the company’s stock worth $5,403,000 after buying an additional 10,003 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its holdings in shares of Acadia Healthcare by 19.4% in the 2nd quarter. Principal Financial Group Inc. now owns 643,521 shares of the company’s stock worth $43,463,000 after buying an additional 104,359 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.